H.R. 7482 — LymeX Authorization Act

This section declares it to be the policy of the United States to (1) engage stakeholders—including academia, nonprofits, industry, small business, entrepreneurs, and government—to facilitate patient-centered innovations in Lyme disease care; (2) foster breakthroughs in health education and public awareness initiatives focused on Lyme disease patients; and (3) accelerate development of next-generation diagnostics that are rapid and patient-focused.

This section authorizes appropriations of $5 million to the Secretary of Health and Human Services for prize competitions under 15 U.S.C. 3719 (i.e., competitions that award prizes to stimulate innovation advancing an agency's mission, such as point solutions, expositions, or participation prizes) to accelerate innovation in the prevention, diagnosis, and treatment of Lyme disease.